Hepatocellular carcinoma: Histologic considerations: Pure, Mixed, and motley

Journal of Clinical Gastroenterology

Volumn 47, Issue SUPPL.1, 2013, Pages

  Mitchell, Kisha A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

combined hepatocellular cholangiocarcinoma; hepatocellular carcinoma; lymphoepitheliallike; sarcomatoid; scirrhous; steatohepatitic

Indexed keywords

ARGINASE; CARCINOEMBRYONIC ANTIGEN; GLUTAMATE AMMONIA LIGASE; GLYPICAN 3; HEAT SHOCK PROTEIN; KI 67 ANTIGEN; POLYCLONAL ANTISERUM;

ALCOHOL LIVER DISEASE; BILE DUCT CARCINOMA; CELL DIFFERENTIATION; CONFERENCE PAPER; CYTOPLASM; DIFFUSE CIRRHOSIS LIKE LIVER CELL CARCINOMA; DUBIN JOHNSON SYNDROME; EXTRAMEDULLARY HEMATOPOIESIS; FIBROLAMELLAR LIVER CELL CARCINOMA; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; LYMPHOEPITHELIOMA; LYMPHOEPITHELIOMA LIKE LIVER CELL CARCINOMA; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SARCOMATOID LIVER CELL CARCINOMA; STEATOHEPATITIC LIVER CELL CARCINOMA;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS;

EID: 84879925101     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318291f237     Document Type: Conference Paper

References (39)

1. Desmet V. Experimentele Levercarcinogenese: Histochemische Studie. Brussels: Presses Academiques Europeennes; 1963
2. Roskams T. Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy. Clin Liver Dis. 2011;15:245-259, vii-x.
3. Kojiro M, Wanless I, Alves V, et al. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology. 2009;49:658-664.
4. Kutami R, Nakashima Y, Nakashima O, et al. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000;33: 282-289. (Pubitemid 30485232)
5. Ishak KG, Goodman ZD, Stocker JT. Hepatocellular Carcinoma. Tumors of The Liver and Intrahepatic Bile Ducts. Bethesda, MD: Armed Forces Institute of Pathology; 2001: 199-230.
6. Yan BC, Gong C, Song J, et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010;34:1147-1154.
7. Kakar S, Gown AM, Goodman ZD, et al. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med. 2007;131: 1648-1654. (Pubitemid 350077461)
8. Goodman ZD. Neoplasms of the liver. Mod Pathol. 2007;20(suppl 1):S49-S60. (Pubitemid 46733654)
9. Timek DT, Shi J, Liu H, et al. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol. 2012;138:203-210.
10. Krings G, Ramachandran R, Jain D, et al. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013. [Epub ahead of print] DOI: 10.1038/modpathol.2012.243.
11. Jakate S, Yabes A, Giusto D, et al. Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis. Am J Surg Pathol. 2010;34:935-941.
12. Abdul-Al HM, Wang G, Makhlouf HR, et al. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma. Int J Surg Pathol. 2010;18:313-318.
13. Malouf GG, Brugieres L, Le Deley MC, et al. Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer. 2012;118:4981-4990.
14. TheiseN,Nakashima O, Park Y, et al. Combined hepatocellular cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, et al, eds.WHO Classification of Tumours of the Digestive System. Lyan, France: IARC Press; 2010:225-227.
15. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25:647-655.
16. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985;55:124-135. (Pubitemid 15198209)
17. Lee CC, Wu CY, Chen JT, et al. Comparing combined hepatocellular- cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study. Hepatogastroenterology. 2002;49: 1487-1490.
18. Tang D, Nagano H, Nakamura M, et al. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg. 2006;10:987-998. (Pubitemid 44037476)
19. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003;33:283-287. (Pubitemid 43115254)
20. Salomao M, Yu WM, Brown RS Jr., et al. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol. 2010;34: 1630-1636.
21. Salomao M, Remotti H, Vaughan R, et al. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Hum Pathol. 2012;43: 737-746.
22. Alexander J, Torbenson M, Wu TT, et al. Nonalcoholic fatty liver disease contributes to hepatocellular carcinoma in noncirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol. 2013. [Epub anead of print] DOI: 10.1111,/jgh.12116.
23. Si MW, Thorson JA, Lauwers GY, et al. Hepatocellular lymphoepithelioma- like carcinoma associated with epstein barr virus: a hitherto unrecognized entity. Diagn Mol Pathol. 2004;13:183-189. (Pubitemid 39121745)
24. Nemolato S, Fanni D, Naccarato AG, et al. Lymphoepitelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Gastroenterol. 2008;14:4694-4696.
25. Emile JF, Adam R, Sebagh M, et al. Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology. 2000;37:523-529. (Pubitemid 32101424)
26. Choi HJ, Choi JH. Hepatocellular carcinoma with lymphoid stroma: report of two cases. Korean J Hepatol. 2008;14:394-398.
27. Chen CJ, Jeng LB, Huang SF. Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J. 2007;30: 172-177.
28. Shirabe K, Matsumata T, Maeda T, et al. A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration-a clinicopathological study. Hepatogastroenterology. 1995;42:996-1001. (Pubitemid 26026468)
29. Wada Y, Nakashima O, Kutami R, et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998;27:407-414. (Pubitemid 28081054)
30. Vortmeyer AO, Kingma DW, Fenton RG, et al. Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Am J Clin Pathol. 1998;109:90-95. (Pubitemid 28023816)
31. Kojiro M, Sugihara S, Kakizoe S, et al. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol. 1989;suppl 23:S4-S8. (Pubitemid 19073746)
32. Hwang S, Lee SG, Lee YJ, et al. Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation. J Gastrointest Surg. 2008;12:718-724.
33. Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer. 1987;59: 310-316. (Pubitemid 17232895)
34. Koo HR, Park MS, Kim MJ, et al. Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases. J Comput Assist Tomogr. 2008;32:745-749.
35. Koda M, Maeda Y, Matsunaga Y, et al. Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol Res. 2003;27:163-167. (Pubitemid 37322178)
36. Nguyen T, Torbenson M, Wu T-T, et al. Morphologic and immunohistochemical features of sarcomatoid hepatocellular carcinoma. Mod Pathol. 2013;26:407A.
37. Salaria SN, Torbenson MS. Mucinous hepatocelluar carcinoma: a previously undescribed variant of hepatocellular carcinoma. Mod Pathol. 2013;26:409A.
38. Bannasch P. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype. World J Gastroenterol. 2012;18:6701-6708.
39. Callea F, Giovannoni I, Stefanelli M, et al. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: histological, histochemical and microbiochemical characterization of the novel variant. Histopathology. 2012;60: 1010-1012.